Rituximab, Anti-CD20, Induces In Vivo Cytokine Release But Does Not Impair Ex Vivo T-Cell Responses

MLA

Carlos A. Vieira, et al. “Rituximab, Anti-CD20, Induces In Vivo Cytokine Release But Does Not Impair Ex Vivo T-Cell Responses.” American Journal of Transplantation, vol. 4, Aug. 2004, pp. 1357–60. EBSCOhost, https://doi.org/10.1111/j.1600-6143.2004.00502.x.

APA

Carlos A. Vieira, Mark D. Pescovitz, Richard A. Sidner, Naomi S. Fineberg, Benita K. Book, & Avinash Agarwal. (2004). Rituximab, Anti-CD20, Induces In Vivo Cytokine Release But Does Not Impair Ex Vivo T-Cell Responses. American Journal of Transplantation, 4, 1357–1360. https://doi.org/10.1111/j.1600-6143.2004.00502.x

Chicago

Carlos A. Vieira, Mark D. Pescovitz, Richard A. Sidner, Naomi S. Fineberg, Benita K. Book, and Avinash Agarwal. 2004. “Rituximab, Anti-CD20, Induces In Vivo Cytokine Release But Does Not Impair Ex Vivo T-Cell Responses.” American Journal of Transplantation 4 (August): 1357–60. doi:10.1111/j.1600-6143.2004.00502.x.